Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed
The Company also confirms its mid-term intention to list on Nasdaq to co-fund late stage development of its Lyme disease... View Article
New member | Vigier Avocats
Making the practice of law an asset! Vigier Avocats is an independent business law with a solid expertise in the... View Article
New member | Olgram
Olgram transforms a natural marine molecule into a drug to stimulate the immune system and develops new classes of antibiotics.... View Article
New member | The Engineering School of University of Rouen Normandie
ESITech or Engineering School for Innovative Technologies, trains general engineers with two possible majors: Physical Engineering and Biological Engineering.... View Article
New member | Cidelec
For over 25 years CIDELEC has designed and manufactured polygraphy and polysomnography devices for the diagnosis of sleep disorders... View Article
New member | Allice
Allice is a union of cooperatives which unites all the French animal selection and reproduction companies and also a Belgian... View Article
New member | Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000... View Article
New member | Caligos
Solène RICHARD is a quality management consultant. She has more than 15 years of experience in the field of quality... View Article
Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million
Member of Atlanpole Biotherapies, Valneva SE (“Valneva” or “the Company”), announced today that the U.S. government Department of Defense (DoD)... View Article
InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of Oral IFB-088
Results show IFB-088 is safe and well tolerated in healthy volunteers Data supports initiation of Phase 2 trial in Charcot-Marie-Tooth... View Article